Replicor Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Replicor Inc..The latest application filed is for "methods for the treatment of hepatitis b and hepatitis d infections".
- Replicor Inc. - Montreal N/A CA
- REPLICOR INC. - Montreal QC CA
- Replicor Inc - Montreal N/A CA
- Replicor Inc -
- Replicor, Inc. - Laval CA
- Replicor Inc. - 500 Cartier Blvd. West, Suite 135 Laval QC
| Patent | Date |
|---|---|
| Oligonucleotide chelate complex methods Grant 9,616,083 - Bazinet , et al. April 11, 2 | 2017-04-11 |
| Methods for the treatment of hepatitis B and hepatitis D virus infections Grant 9,603,865 - Vaillant March 28, 2 | 2017-03-28 |
| Methods for the treatment of hepatitis B and hepatitis D infections Grant 9,533,003 - Bazinet , et al. January 3, 2 | 2017-01-03 |
| Oligonucleotide chelate complex--polypeptide compositions and methods Grant 9,492,506 - Bazinet , et al. November 15, 2 | 2016-11-15 |
| Methods For The Treatment Of Hepatitis B And Hepatitis D Infections App 20160263143 - Bazinet; Michel ; et al. | 2016-09-15 |
| Methods for the treatment of hepatitis B and hepatitis D infections Grant 9,284,556 - Bazinet , et al. March 15, 2 | 2016-03-15 |
| Methods For The Treatment Of Hepatitis B And Hepatitis D Virus Infections App 20160008393 - VAILLANT; Andrew | 2016-01-14 |
| Methods for the treatment of hepatitis B and hepatitis D infections Grant 9,200,283 - Bazinet , et al. December 1, 2 | 2015-12-01 |
| Methods for the treatment of hepatitis B and hepatitis D infections Grant 9,133,458 - Bazinet , et al. September 15, 2 | 2015-09-15 |
| Methods For The Treatment Of Hepatitis B And Hepatitis D Infections App 20140369963 - Bazinet; Michel ; et al. | 2014-12-18 |
| Methods For The Treatment Of Hepatitis B And Hepatitis D Infections App 20140369962 - Bazinet; Michel ; et al. | 2014-12-18 |
| Oligonucleotide chelate complexes Grant 8,716,259 - Vaillant , et al. May 6, 2 | 2014-05-06 |
| Methods For The Treatment Of Hepatitis B And Hepatitis D Infections App 20140065102 - BAZINET; Michel ; et al. | 2014-03-06 |
| Oligonucleotide Chelate Complex - Polypeptide Compositions And Methods App 20130309201 - BAZINET; Michel ; et al. | 2013-11-21 |
| Oligonucleotide Chelate Complex Methods App 20130310445 - BAZINET; Michel ; et al. | 2013-11-21 |
| Oligonucleotide Chelate Complexes App 20130296410 - VAILLANT; Andrew ; et al. | 2013-11-07 |
| Oligonucleotide chelate complexes Grant 8,513,211 - Vaillant , et al. August 20, 2 | 2013-08-20 |
| Oligonucleotide Chelate Complexes App 20120046348 - Vaillant; Andrew ; et al. | 2012-02-23 |
| Antiviral oligonucleotides targeting HBV Grant 8,067,385 - Vaillant , et al. November 29, 2 | 2011-11-29 |
| Antiviral oligonucleotides targeting viral families Grant 8,008,270 - Vaillant , et al. August 30, 2 | 2011-08-30 |
| Antiviral oligonucleotides Grant 8,008,269 - Vaillant , et al. August 30, 2 | 2011-08-30 |
| Antiviral oligonucleotides Grant 7,358,068 - Vaillant , et al. April 15, 2 | 2008-04-15 |
| Oligonucleotides targeting prion diseases App 20070123480 - Juteau; Jean-Marc ; et al. | 2007-05-31 |
| Antiviral oligonucleotides targeting viral families App 20050196382 - Vaillant, Andrew ; et al. | 2005-09-08 |
| Antiviral oligonucleotides App 20050176661 - Vaillant, Andrew ; et al. | 2005-08-11 |
| Antiviral oligonucleotides targeting viral families App 20050153912 - Vaillant, Andrew ; et al. | 2005-07-14 |
| Antiviral oligonucleotides targeting RSV App 20040229828 - Vaillant, Andrew ; et al. | 2004-11-18 |
| Methods for identifying antiviral oligonucleotides App 20040170959 - Vaillant, Andrew ; et al. | 2004-09-02 |
| Antiviral oligonucleotides targeting HIV App 20040171568 - Vaillant, Andrew ; et al. | 2004-09-02 |
| Antiviral oligonucleotides targeting HBV App 20040162253 - Vaillant, Andrew ; et al. | 2004-08-19 |
| Antiviral oligonucleotides targeting HSV and CMV App 20040162254 - Vaillant, Andrew ; et al. | 2004-08-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 